Skip to main content

Artemis Medicare Reports Q2 Revenue of ₹3.1 Billion, Up From ₹2.75 Billion YoY

Artemis Medicare delivered steady top-line growth in Q2, driven by higher bed occupancy, improved operational realizations, and expanding margins across core hospital operations.

Author Image
Sahi Markets
Published: 30 Oct 2026, 10:18 PM IST (1 hour ago)
Last Updated: 30 Oct 2026, 10:18 PM IST (1 hour ago)
1 min read
Reviewed by Arpit Seth

Market snapshot: Artemis Medicare Services Ltd reported its Q2 results, with revenue rising to ₹3.10 billion (₹310 crore) compared to ₹2.75 billion (₹275 crore) in the corresponding period of the previous fiscal year.

Data Snapshot

  • Q2 revenue from operations reached ₹310 crore (₹3.10 billion) compared to ₹275 crore (₹2.75 billion) in the prior-year quarter.
  • Q2 EBITDA increased 21.8% YoY to ₹70.96 crore with EBITDA margin expanding 141 bps to 23.8%.
  • Q2 Profit After Tax (PAT) grew 25.9% YoY to ₹40.43 crore with net margin reaching 13.5%.

What's Changed

  • Revenue expanded YoY from ₹275 crore to ₹310 crore in Q2.
  • EBITDA margin improved by 141 bps to 23.8%.

Key Takeaways

  • Steady revenue performance supported by operational efficiencies.
  • Operating profit and net profit margins demonstrated healthy year-on-year expansion.
  • Capacity expansion initiatives remain on track to add over 200 additional beds.

SAHI Perspective

Artemis Medicare continues to demonstrate strong operational execution in its core healthcare business. Margin expansion highlights operating leverage as patient volume and specialty bed utilization increase.

Market Implications

The positive Q2 performance reflects stable demand in tertiary healthcare services, supporting earnings trajectory as facility expansions mature.

Trading Signals

Market Bias: Bullish

Revenue grew YoY to ₹310 crore alongside EBITDA margin expansion to 23.8% and PAT growth of 25.9% YoY.

Overweight: Healthcare Services, Hospitals

Trigger Factors:

  • Sustained ARPOB metrics in core Gurugram hospital
  • Execution on planned 200+ bed expansion

Time Horizon: Near-term (0-3 months)

Industry Context

Indian hospital operators benefit from rising average revenue per occupied bed and growing structural demand for specialized care in urban hubs.

Key Risks to Watch

  • Increases in clinical staff costs and medical consumables
  • Regulatory policy changes on healthcare tariff structures

Recent Developments

In October 2026, Artemis Medicare detailed plans to expand total bed capacity to 900+ beds by acquiring additional floor area ratio (FAR) at its main Gurugram facility.

Closing Insight

With strong top-line revenue growth and expanding profitability margins, Artemis Medicare demonstrates steady operational health backing its future bed capacity expansion.

High Performance Trading with SAHI.

Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.

Open Free Account

Frequently Asked Questions (FAQs)

All topics

Add Sahi as a Preferred Source on Google

Click the link, confirm the box next to sahi.com is checked — ignore any other results.